Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma

被引：10

作者：

Cho, Chun-Hung ^{[1
]}

Hwang, Wen-Lee ^{[1
]}

Cheng, Shao-Bin ^{[2
]}

Lee, Teng-Yu ^{[3
]}

Teng, Chien-Lin ^{[1
,4
,5
]}

机构：

[1] Taichung Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taichung 407, Taiwan

[2] Taichung Vet Gen Hosp, Dept Surg, Div Gen Surg, Taichung 407, Taiwan

[3] Taichung Vet Gen Hosp, Dept Med, Div Gastroenterol, Taichung 407, Taiwan

[4] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan

[5] Chung Shan Med Univ, Dept Med, Taichung, Taiwan

来源：

ANNALS OF HEMATOLOGY | 2011年 / 90卷 / 01期

关键词：

VIRUS;

D O I：

10.1007/s00277-010-0962-9

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：111 / 112

页数：2

共 10 条

[1]

Antiviral drug resistance: Clinical consequences and molecular aspects [J].

Bartholorneusz, A ;

Locarnini, SA .

SEMINARS IN LIVER DISEASE, 2006, 26 (02) :162-170

[2]

Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B [J].

Chang, Ting-Tsung ;

Lai, Ching-Lung ;

Yoon, Seung Kew ;

Lee, Samuel S. ;

Coelho, Henrique Sergio M. ;

Carrilho, Flair Jose ;

Poordad, Fred ;

Halota, Waldemar ;

Horsmans, Yves ;

Tsai, Naoky ;

Zhang, Hui ;

Tenney, Daniel J. ;

Tamez, Ricardo ;

Iloeje, Uchenna .

HEPATOLOGY, 2010, 51 (02) :422-430

[3]

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma [J].

He, Yi-Fu ;

Li, Yu-Hong ;

Wang, Feng-Hua ;

Jiang, Wen-Qi ;

Xu, Rui-Hua ;

Sun, Xiao-Fei ;

Xia, Zhong-Jun ;

Huang, Hui-Qiang ;

Lin, Tong-Yu ;

Zhang, Li ;

Bao, Shi-Ping ;

He, You-Jian ;

Guan, Zhong-zhen .

ANNALS OF HEMATOLOGY, 2008, 87 (06) :481-485

[4]

Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia [J].

Lim, SH ;

Zhang, Y ;

Wang, Z ;

Esler, WV ;

Beggs, D ;

Pruitt, B ;

Hancock, P ;

Townsend, M .

BONE MARROW TRANSPLANTATION, 2005, 35 (02) :207-208

[5]

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients [J].

Pei, Sung-Nan ;

Chen, Chien-Hung ;

Lee, Chuan-Mo ;

Wang, Ming-Chung ;

Ma, Ming-Chun ;

Hu, Tsung-Hui ;

Kuo, Ching-Yuan .

ANNALS OF HEMATOLOGY, 2010, 89 (03) :255-262

[6]

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis [J].

Pyrpasopoulou, Athina ;

Douma, Stella ;

Vassiliadis, Themistoklis ;

Chatzimichailidou, Sofia ;

Triantafyllou, Areti ;

Aslanidis, Spyros .

RHEUMATOLOGY INTERNATIONAL, 2011, 31 (03) :403-404

[7]

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido [J].

Tsutsumi, Yutaka ;

Shigematsu, Akio ;

Hashino, Satoshi ;

Tanaka, Junji ;

Chiba, Kouji ;

Masauzi, Nobuo ;

Kobayashi, Hajime ;

Kurosawa, Mitsutoshi ;

Iwasaki, Hiroshi ;

Morioka, Masanobu ;

Asaka, Masahiro ;

Imamura, Masahiro .

ANNALS OF HEMATOLOGY, 2009, 88 (04) :375-377

[8]

Rituximab treatment results in impaired secondary humoral immune responsiveness [J].

van der Kolk, LE ;

Baars, JW ;

Prins, MH ;

van Oers, MHJ .

BLOOD, 2002, 100 (06) :2257-2259

[9]

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial [J].

van Oers, Marinus H. J. ;

Klasa, Richard ;

Marcus, Robert E. ;

Wolf, Max ;

Kimby, Eva ;

Gascoyne, Randy D. ;

Jack, Andrew ;

van't Veer, Mars ;

Vranovsky, Andrei ;

Holte, Harald ;

van Glabbeke, Martine ;

Teodorovic, Ivana ;

Rozewicz, Cynthia ;

Hagenbeek, Anton .

BLOOD, 2006, 108 (10) :3295-3301

[10]

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy [J].

Yeo, W ;

Johnson, PJ .

HEPATOLOGY, 2006, 43 (02) :209-220

← 1 →